These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5658235)

  • 1. [The use of polysponin in patients with coronary atherosclerosis].
    Solomonova LN
    Kardiologiia; 1968 Feb; 8(2):71-4. PubMed ID: 5658235
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with polysponin therapy of atherosclerosis].
    Milimovka ME; Konovalov MN; Rybnikov NI; Dimant MI
    Vrach Delo; 1971 Jan; (1):63-5. PubMed ID: 5576585
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of retabolyl on the lipid and protein metabolism of coronary atherosclerosis patients].
    Savenkov PM; Segal' RG
    Kardiologiia; 1969 Jul; 9(7):95-100. PubMed ID: 5372695
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of cetamiphen and nicotinic acid in the treatment of patients with coronary atherosclerosis].
    Savenkov PM
    Kardiologiia; 1967 Apr; 7(4):50-3. PubMed ID: 5598475
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of various preparations on hyperuricemia in coronary arteriosclerosis].
    Anisimov VE; Goliakov VN; Semavin IE
    Ter Arkh; 1977; 49(9):134-6. PubMed ID: 73228
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of atromide-S (chlorfibrate) for the treatment of patients with coronary arteriosclerosis].
    Zadionchenko VS; Arshakuni RO; Zharov EI; Martynov AI; Liusov VA; Belousov IuB
    Kardiologiia; 1969 Apr; 9(4):73-7. PubMed ID: 5803361
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of gypsozide on the course of experimental cholesterol atherosclerosis in rabbits].
    Iatsyno AI
    Farmakol Toksikol; 1969; 32(6):687-9. PubMed ID: 5393461
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical prevention of coronary heart disease through cholesterol-lowering therapy.
    Grundy SM
    Curr Ther Endocrinol Metab; 1997; 6():520-6. PubMed ID: 9174799
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
    el-Mehairy MM; Attia O; Nabih AE; Nassar I; Ibrahim WN
    J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prolonged use of atromid in patients with coronary arteriosclerosis].
    Zadionchenko VS
    Kardiologiia; 1967 Oct; 7(10):32-5. PubMed ID: 5607197
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 12. Simvastatin decreases mortality.
    Shaughnessy AF; Slawson DC
    J Fam Pract; 1995 May; 40(5):498-9. PubMed ID: 7730777
    [No Abstract]   [Full Text] [Related]  

  • 13. The benefit of lowering cholesterol: relative risk can be absolutely misleading!
    Meleady R; Graham IM
    Ir J Med Sci; 1998; 167(2):92-3. PubMed ID: 9638023
    [No Abstract]   [Full Text] [Related]  

  • 14. Misconceptions about cholesterol.
    French J; White H
    N Z Med J; 1990 Jan; 103(882):19-20. PubMed ID: 2304673
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of determining serum cholesterol levels in patients with coronary heart disease].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2545-8. PubMed ID: 9555153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abnormal lipid metabolism and coronary insufficiency].
    Murakami M; Sekimoto H; Tanaka I; Seo M; Takegoshi T
    Saishin Igaku; 1970 Jan; 25(1):101-9. PubMed ID: 5450347
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of clofibrate on raised serum lipid levels.
    Smith RB; Prior IA; Cooke NJ
    N Z Med J; 1968 Oct; 68(437):231-4. PubMed ID: 5247681
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic agents for lipid metabolism disorders--with special reference to arterial diseases].
    Murakami M; Sekimoto H; Nagai T; Nakata I; Takekoshi T
    Nihon Rinsho; 1970 Mar; 28 Suppl():696-9. PubMed ID: 5430846
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative evaluation of treatment of patients with coronary atherosclerosis with nicatol and nicotinic acid].
    Ivanchenko FT
    Vrach Delo; 1967 Jan; 1():76-80. PubMed ID: 4895148
    [No Abstract]   [Full Text] [Related]  

  • 20. The 4S study: a critical review.
    Pauciullo P
    Pharmacol Res; 1997 Mar; 35(3):165-6. PubMed ID: 9229401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.